1-3 of 3
Elisa Gallerani
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract P3-12-07: SARELIFE study: Safety and efficacy of Sacituzumab Govitecan (SG) in pretreated metastatic triple negative breast cancer (mTNBC): a multicentric, real-life study

Free
Elena Florio, Giovanna Catania, Elisa Gallerani, Giuliana D'Auria, Paola Tagliabue, Andrea Botticelli, Rita Chiari, Federica Villa, Alessandra Chirco, Monica Giordano, Mirco Pistelli, Francesco Verderame, Annalisa Bramati, Agnese Latorre, Simonetta Chiara Stani, Patrizia Vici, Icro Meattini, Beatrice Tedesco, Azzurra Irelli, Serena Madaro, Giusy Ricciardi, Laura Roazzi, Luigi Rossi, Luigia Stefania Stucci, Sara Zanelli, Barbara Tagliaferri, Lorenzo Ruggieri, Ottavia Amato, Anna Gambaro, Davide Dalu, Alessio Midali, Francesca Galli, Eliana Rulli, Nicla La Verde
Journal: Clinical Cancer Research
Clin Cancer Res (2025) 31 (12_Supplement): P3-12-07.
https://doi.org/10.1158/1557-3265.SABCS24-P3-12-07
Published: 13 June 2025
View article titled, Abstract P3-12-07: SARELIFE study: Safety and efficacy of Sacituzumab Govitecan (SG) in pretreated metastatic triple negative breast cancer (mTNBC): a multicentric, real-life study
Journal Articles

Predictive Effect of IGFBP-3 on Low-Dose Tamoxifen Efficacy in Noninvasive Breast Cancer in the Phase III Tam-01 Trial

Available to Purchase
Harriet Johansson, Debora Macis, Martino Oliva, Matteo Puntoni, Eva Blondeaux, Aliana Guerrieri-Gonzaga, Valentina Aristarco, Irene Maria Briata, Tania Buttiron-Webber, Luca Boni, Matteo Lazzeroni, Davide Serrano, Livia Giordano, Maria Digennaro, Laura Cortesi, Francesco Millo, Katia Cagossi, Giuseppe Aprile, Fabio Falcini, Elisa Gallerani, Bernardo Bonanni, Andrea DeCensi
Journal: Clinical Cancer Research
Clin Cancer Res (2025) 31 (10): 1841–1846.
https://doi.org/10.1158/1078-0432.CCR-24-2987
Published: 15 May 2025
View article titled, Predictive Effect of IGFBP-3 on Low-Dose Tamoxifen Efficacy in Noninvasive Breast Cancer in the Phase III Tam-01 Trial
Open the PDF for Predictive Effect of IGFBP-3 on Low-Dose Tamoxifen Efficacy in Noninvasive Breast Cancer in the Phase III Tam-01 Trial in another window
Includes: Supplementary data
Journal Articles

Dose–Response Relationship in Phase I Clinical Trials: A European Drug Development Network (EDDN) Collaboration Study

Free
Victor Moreno García, David Olmos, Carlos Gomez-Roca, Philippe A. Cassier, Rafael Morales-Barrera, Gianluca Del Conte, Elisa Gallerani, Andre T. Brunetto, Patrick Schöffski, Silvia Marsoni, Jan H.M. Schellens, Nicolas Penel, Emile Voest, Jeffrey Evans, Ruth Plummer, Richard H. Wilson, Jean Charles Soria, Josep Tabernero, Jaap Verweij, Stan B. Kaye
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (22): 5663–5671.
https://doi.org/10.1158/1078-0432.CCR-14-0719
Published: 13 November 2014
View article titled, Dose–Response Relationship in Phase I Clinical Trials: A European Drug Development Network (EDDN) Collaboration Study
Open the PDF for Dose–Response Relationship in Phase I Clinical Trials: A European Drug Development Network (EDDN) Collaboration Study in another window
Includes: Supplementary data